Bank of America
ATHE

Bank of America’s Alterity Therapeutics ATHE Stock Holding History

Bank of America’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10
Closed – – 6815
2020
Q1 		$0 Buy
+10
New +$69 ﹤0.01% 6827
2019
Q1 		– Sell
-27
Closed – – 7086
2018
Q4 		$0 Hold
27
– – ﹤0.01% 7088
2018
Q3 		$1K Hold
27
– – ﹤0.01% 7100
2018
Q2 		$1K Hold
27
– – ﹤0.01% 6953
2018
Q1 		$1K Sell
27
-66
-71% -$1.77K ﹤0.01% 6946
2017
Q4 		$3K Sell
93
-25
-21% -$784 ﹤0.01% 6800
2017
Q3 		$4K Buy
118
+25
+27% +$679 ﹤0.01% 6768
2017
Q2 		$2K Sell
93
-17
-15% -$423 ﹤0.01% 6732
2017
Q1 		$3K Buy
110
+66
+150% +$1.56K ﹤0.01% 6734
2016
Q4 		$1K Sell
44
-8
-15% -$214 ﹤0.01% 6891
2016
Q3 		$2K Sell
52
-300
-85% -$14.9K ﹤0.01% 6800
2016
Q2 		$17K Sell
352
-41
-10% -$1.58K ﹤0.01% 6312
2016
Q1 		$10K Sell
393
-180
-31% -$6.01K ﹤0.01% 6388
2015
Q4 		$25K Sell
573
-154
-21% -$7.83K ﹤0.01% 6340
2015
Q3 		$39K Buy
727
+210
+41% +$13.3K ﹤0.01% 6041
2015
Q2 		$36K Sell
517
-633
-55% -$47.6K ﹤0.01% 6090
2015
Q1 		$77K Sell
1,150
-50
-4% -$3.99K ﹤0.01% 5445
2014
Q4 		$118K Buy
1,200
+500
+71% +$54.1K ﹤0.01% 5765
2014
Q3 		$90K Buy
700
+50
+8% +$6.69K ﹤0.01% 6087
2014
Q2 		$88K Sell
650
-150
-19% -$17.1K ﹤0.01% 6229
2014
Q1 		$134K Buy
800
+217
+37% +$120K ﹤0.01% 5740
2013
Q4 		$245K Buy
583
+83
+17% +$24.8K ﹤0.01% 5403
2013
Q3 		$123K Buy
500
+350
+233% +$80.3K ﹤0.01% 5811
2013
Q2 		$21K Buy
+150
New +$20.4K ﹤0.01% 6935

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EP
Eudaimonia Partners Winchester, Tennessee $420M AUM 27.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
OIA
Optimum Investment Advisors Chicago, Illinois $252M AUM 26.44% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Bank of America's ATHE Position: Q2 2020 in Review

Bank of America sold out of Alterity Therapeutics (ATHE) in Q2 2020, closing a stake of 10 shares.

Bank of America first reported a position in ATHE in Q2 2013 and held it in 24 quarters. The position peaked at $245K in Q4 2013. 14 funds tracked by Wall St. Rank hold ATHE as of Q2 2020.

  • Bank of America reported no remaining Alterity Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Bank of America sold 10 Alterity Therapeutics shares in Q2 2020.
  • Bank of America first reported a position in Alterity Therapeutics in Q2 2013 and held it in 24 quarters.
  • Bank of America's Alterity Therapeutics position peaked at $245K in Q4 2013.
  • 14 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2020.

Based on Bank of America's 13F filing for Q2 2020, filed 14 Aug 2020.